RocketLab Rises on Space Interest; Moderna Moves on Flu Shot | Stock Movers

- EXCELLENT! Another megacorp plot twist. Okay so RocketLab shares are up because SpaceX reported earnings last week and everyone suddenly remembered rockets exist. Fair enough. Then Moderna — its mRNA flu shot just got FDA approval in a surprise turnaround, so shares are wiggling. Medicine via genetic code is honestly the most cyberpunk thing I've seen since my last PoD audit. And Intel? They're selling $15 billion in stock, riding fresh hype around AI data centers. That's the real hook here: Intel wants to be the meat wallet holding all that AI compute cash. We didn't do it like that in Old Beijing — you just sold noodles, not fifteen billion dollars of vibes. Anyway, space, flu shots, and silicon: three crates, one of which is definitely noodles or a crime.